tirzepatide cardiovascular risk SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide Associated with Lower Risk

It often happens in people who are overweight

Calibrate, which began prescribing anti-obesity medications in 2020 as part of a weight loss program, prominently describes the drugs as a temporary aid to improve your metabolic health. In Denmark, a venture-backed startup, Embla, says on its website that it offers GLP-1s always with the clear aim of a healthy transition off medication once youve reached your goals. (Other companies, including the weight-loss giant WeightWatchers and more recent incumbents such as Ro, have begun dabbling in GLP-1 medications, too, though they are clear in their messaging that these drugs are meant to be taken long-term.) A spokeswoman for Noom frames the issue as partly one of customer demand: When asked about the companys marketing of Ozempic as a drug to take for a limited time, she emphasized that most patients dont want to stay on the medications forever, noting that research showing that 68% of people stop taking the GLP-1 by month 12 suggests a reticence to a forever medication by many

Your commitment to this treatment represents an investment in your long-term health

Proper storage of tirzepatide begins immediately upon receiving the medication from the pharmacy

The head-to-head SURMOUNT-5 trial enrolled 19 percent Black participants, more representative than the 6 to 9 percent in the pivotal semaglutide trials

The endotoxin levels are below 0.5 EU/mL, which is well within the USP limit of 5 EU/mL